AI Article Synopsis

  • Monthly reports tracking CPOE usage by physicians can encourage adoption by highlighting their contributions to patient safety and quality improvement, especially among those affected by performance-based financial incentives.
  • Misattributions of order sources can undermine physician confidence and motivation to use CPOE effectively, which could have implications for patient safety and legal matters.
  • In a study of one hospitalist group, 4.18% of orders were incorrectly attributed, primarily from nursing (42%) and pharmacy (38%), indicating the need for improved order management protocols to maintain accurate CPOE reporting.

Article Abstract

Background: One strategy to foster adoption of computerized provider order entry (CPOE) by physicians is the monthly distribution of a list identifying the number and use rate percentage of orders entered electronically versus on paper by each physician in the facility. Physicians care about CPOE use rate reports because they support the patient safety and quality improvement objectives of CPOE implementation. Certain physician groups are also motivated because they participate in contracted financial and performance arrangements that include incentive payments or financial penalties for meeting (or failing to meet) a specified CPOE use rate target. Misattribution of order sources can hinder accurate measurement of individual physician CPOE use and can thereby undermine providers' confidence in their reported performance, as well as their motivation to utilize CPOE. Misattribution of order sources also has significant patient safety, quality, and medicolegal implications.

Objective: This analysis sought to evaluate the magnitude and sources of misattribution among hospitalists with high CPOE use and, if misattribution was found, to formulate strategies to prevent and reduce its recurrence, thereby ensuring the integrity and credibility of individual and facility CPOE use rate reporting.

Methods: A detailed manual order source review and validation of all orders issued by one hospitalist group at a midsize community hospital was conducted for a one-month study period.

Results: We found that a small but not dismissible percentage of orders issued by hospitalists-up to 4.18 percent (95 percent confidence interval, 3.84-4.56 percent) per month-were attributed inaccurately. Sources of misattribution by department or function were as follows: nursing, 42 percent; pharmacy, 38 percent; laboratory, 15 percent; unit clerk, 3 percent; and radiology, 2 percent. Order management and protocol were the most common correct order sources that were incorrectly attributed.

Conclusion: Order source misattribution can negatively affect reported provider CPOE use rates and should be investigated if providers perceive discrepancies between reported rates and their actual performance. Preventive education and communication efforts across departments can help prevent and reduce misattribution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430133PMC

Publication Analysis

Top Keywords

order source
12
cpoe rate
12
order sources
12
cpoe
10
misattribution
8
source misattribution
8
computerized provider
8
order
8
provider order
8
order entry
8

Similar Publications

Phosphorus (P) movement in soils is influenced by flow velocities, diffusion rates, and several soil characteristics and properties. In acidic soils, P is tightly bound to soil particles, reducing its availability to plants. Organomineral fertilizers combine organic matter with mineral nutrients, enhancing P fertilization efficiency, and reducing environmental impacts.

View Article and Find Full Text PDF

Background: It is now widely acknowledged that diet, lifestyle, and environmental exposures largely affect an individual's metabolic state in health and disease, including the brain. Metabolomics has demonstrated its potential to enable exciting discoveries in brain health, facilitated by advances in analytical and informatics techniques. Here, we highlighted the use of MS/MS-based untargeted metabolomics to study the diet and medication exposure of cognitively declined cohorts through the newly developed FoodMASST and DrugMASST tools.

View Article and Find Full Text PDF

While progress has been made in recent years, there are still no suitable and accepted , or models that can be used to accurately predict whether a chemical substance has the intrinsic property to cause immune-mediated chemical respiratory allergy, typically manifested as allergic asthma or allergic rhinitis which represents a severe health hazard. Regulatory authorities have relied primarily on clinical evidence (case reports, clinical databases, worker exposure studies) to classify substances as respiratory sensitizers, but this evidence can lack a proven immunological mechanism which is necessary to identify substances which can cause life-long sensitization and clinically relevant allergic symptoms in the respiratory tract in an exposed population (such respiratory allergens may be considered as "true" sensitizers, in analogy to the definition of skin sensitization, and in contrast to respiratory irritants). In light of this, the European Center for Ecotoxicology and Toxicology of Chemicals convened a Task Force to evaluate the types of clinical methods and data sources and the implications of relying on such data for regulatory decision making from a scientific perspective.

View Article and Find Full Text PDF

Background: Dementia, a growing health crisis, disproportionally affects persons from racial/ethnic backgrounds and individuals with comorbidities. Latelife change in cognition is complex and nonlinear, as well as differential for these individuals. These individuals are also largely underrepresented in clinical trials.

View Article and Find Full Text PDF

Background: Currently, the diagnosis of Alzheimer's disease dementia (ADD) is determined based on clinical criteria, as well as specific imaging and cerebrospinal fluid (CSF) biomarker profiles. However, healthcare professionals face a variety of challenges that hinder their application, such as the interpretation and integration or large amounts of data derived from neuropsychological assessment, the importance attributed to each source of information and the impact of unknown variables, among others. Therefore, this research focuses on the development of a computerized diagnostic tool based on Artificial Intelligence (AI), to strengthen the capacity of healthcare professionals in the identification and diagnosis of ADD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!